Literature DB >> 29322606

Association of tumour-infiltrating regulatory T cells with adverse outcomes in dogs with malignant tumours.

K Sakai1, S Maeda1, Y Yamada1, J K Chambers2, K Uchida2, H Nakayama2, T Yonezawa1, N Matsuki1.   

Abstract

Regulatory T cells (Tregs) infiltrate into a variety of tumour tissues and associate with poor prognosis in humans. However, data on association of Treg infiltration with prognosis is limited in canine tumours. The purpose of this study was to examine the number of tumour-infiltrating Tregs and its association with overall survival (OS) in dogs with malignant tumours. The following 168 canine tumours were included: 37 oral malignant melanomas (OMMs); 14 oral squamous cell carcinomas (OSCCs); 16 pulmonary adenocarcinomas (PAs); 37 mammary carcinomas (MCs); 36 mast cell tumours (MCTs) and 28 hepatocellular carcinomas (HCCs). Normal tissues were obtained from 8 healthy dogs as controls. The number of forkhead box P3 (Foxp3)-positive Tregs in intratumoral and peritumoral areas was investigated by immunohistochemistry. OS was compared between high and low Treg groups. The number of intratumoral and peritumoral Foxp3-positive Tregs was significantly higher in OMM, OSCC, PA and MC compared with each normal tissue. There were few Foxp3-positive Tregs in MCT and HCC. With intratumoral Tregs, the OS in the high Treg group was significantly shorter than that in the low Treg group in OMM, OSCC and PA. With peritumoral Tregs, there was no significant difference for OS between the 2 groups in each tumour type. These results suggest that Tregs infiltrate into a variety of canine tumours and the abundance of Tregs are associated with poor prognosis in some solid tumour types.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  Foxp3; Tregs; canine; prognosis; solid tumours

Mesh:

Year:  2018        PMID: 29322606     DOI: 10.1111/vco.12383

Source DB:  PubMed          Journal:  Vet Comp Oncol        ISSN: 1476-5810            Impact factor:   2.613


  5 in total

1.  In-situ vaccination using focused ultrasound heating and anti-CD-40 agonistic antibody enhances T-cell mediated local and abscopal effects in murine melanoma.

Authors:  Mohit Pratap Singh; Sri Nandhini Sethuraman; Jerry Ritchey; Steven Fiering; Chandan Guha; Jerry Malayer; Ashish Ranjan
Journal:  Int J Hyperthermia       Date:  2019-11       Impact factor: 3.914

Review 2.  Know Thy Model: Charting Molecular Homology in Stromal Reprogramming Between Canine and Human Mammary Tumors.

Authors:  Enni Markkanen
Journal:  Front Cell Dev Biol       Date:  2019-12-17

3.  T Cell Immune Profiles of Blood and Tumor in Dogs Diagnosed With Malignant Melanoma.

Authors:  Ellen E Sparger; Hong Chang; Ning Chin; Robert B Rebhun; Sita S Withers; Hung Kieu; Robert J Canter; Arta M Monjazeb; Michael S Kent
Journal:  Front Vet Sci       Date:  2021-12-02

4.  Assessment of postoperative adjuvant treatment using toceranib phosphate against adenocarcinoma in dogs.

Authors:  Hiroki Yamazaki; Toshiyuki Tanaka; Keiichiro Mie; Hidetaka Nishida; Naoki Miura; Hideo Akiyoshi
Journal:  J Vet Intern Med       Date:  2020-04-08       Impact factor: 3.333

5.  Analysis of single-cell RNAseq identifies transitional states of T cells associated with hepatocellular carcinoma.

Authors:  Yanying Yang; Fangming Liu; Weiren Liu; Mingyue Ma; Jie Gao; Yan Lu; Li-Hao Huang; Xiaoying Li; Yinghong Shi; Xiangdong Wang; Duojiao Wu
Journal:  Clin Transl Med       Date:  2020-07-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.